GenEndeavor is a molecular diagnostics technology tools company on a mission to prevent genetic and infectious disease progression by quickly and accurately detecting pathological biomarkers in early stages. Since inception, GenEndeavor has been building a new generation of technologies within the company's Non-Enzymatic Amplification Technology (NEAT) platform to break through detection barriers that exist today in order to make an impact on healthcare. At GenEndeavor, we’re looking for partnerships to translate our new platform into rapid early-detection tests that will enable ovarian cancer screening, one-hour sepsis pathogen identification, point-of-care childhood TB testing, and point-of-presentation airborne pathogen detection and monitoring. GenEndeavor is led by a team of deeply passionate and dedicated specialists on a mission to make transformational changes to healthcare.